Increased RNA editing in EAAT2 pre-mRNA from amyotrophic lateral sclerosis patients: Involvement of a cryptic polyadenylation site

Neuroscience Letters

Volumn 497, Issue 2, 2011, Pages 139-143

  Flomen, Rachel ^a,b   Makoff, Andrew ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Glutamate transporter; Inosine; Motor neurone disease; Polyadenylation; RNA editing; Stem loop

Indexed keywords

ADENINE; EXCITATORY AMINO ACID TRANSPORTER 2; INOSINE; MESSENGER RNA PRECURSOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CEREBELLUM; CONTROLLED STUDY; INTRON; MOTOR CORTEX; NONHUMAN; POLYADENYLATION; PRIMATE; PRIORITY JOURNAL; RNA EDITING; SIGNAL TRANSDUCTION; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL LINE, TUMOR; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GORILLA GORILLA; HUMANS; HYLOBATES; MOTOR CORTEX; PAN TROGLODYTES; POLYADENYLATION; RNA EDITING; RNA PRECURSORS; RNA SPLICE SITES; SPINAL CORD; UP-REGULATION;

EID: 79956307266     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.047     Document Type: Article

References (26)

1. Boillee S., Velde C.V., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
2. van Blitterswijk M., Landers J.E. RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics 2010, 11:275-290.
3. Shaw P.J., Ince P.G. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 1997, 244:S3-S14. [Suppl 2].
4. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
5. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998, 20:589-602.
6. Meyer T., Fromm A., Münch C., Schwalenstöcker B., Fray A.E., Ince P.G., Stamm S., Grön G., Ludolph A.C., Shaw P.J. The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals. J. Neurol. Sci. 1999, 170:45-50.
7. Flowers J.M., Powell J.F., Leigh P.N., Andersen P., Shaw C.E. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann. Neurol. 2001, 49:643-649.
8. Seeburg P.H., Higuchi M., Sprengel R. RNA editing of brain glutamate receptor channels: mechanism and physiology. Brain Res. Rev. 1998, 26:217-229.
9. Blow M., Futreal P.A., Wooster R., Stratton M.R. A survey of RNA editing in human brain. Genome Res. 2004, 14:2379-2387.
10. Flomen R., Knight J., Sham P., Kerwin R., Makoff A. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res. 2004, 32:2113-2122.
11. Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004, 427:801.
12. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial " Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J. Neurol. Sci. 1994, 124:96-107. Suppl.
13. Matzura O., Wennborg A. RNAdraw: an integrated program for RNA secondary structure calculation and analysis under 32-bit Microsoft Windows. Comput. Appl. Biosci. 1996, 12:247-249.
14. Wright D.J., Rice J.L., Yanker D.M., Znosko B.M. Nearest neighbor parameters for inosine-uridine pairs in RNA duplexes. Biochemistry 2007, 46:4625-4634.
15. Zhao J., Hyman L., Moore C. Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev. 1999, 63:405-445.
16. Mackenzie I.R., Feldman H.H. Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. J. Neuropathol. Exp. Neurol. 2005, 64:730-739.
17. Tian B., Hu J., Zhang H., Lutz C.S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 2005, 33:201-212.
18. Das A.T., Klaver B., Berkhout B. A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J. Virol. 1999, 73:81-91.
19. Rattray M., Bendotti C. Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?. Exp. Neurol. 2006, 201:15-23.
20. Guo H., Lai L., Butchbach M.E., Stockinger M.P., Shan X., Bishop G.A., Lin C.L. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum. Mol. Genet. 2003, 12:2519-2532.
21. Pardo A.C., Wong V., Benson L.M., Dykes M., Tanaka K., Rothstein J.D., Maragakis N.J. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice. Exp. Neurol. 2006, 201:120-130.
22. Brusa R., Zimmermann F., Koh D.S., Feldmeyer D., Gass P., Seeburg P.H., Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680.
23. Cenci C., Barzotti R., Galeano F., Corbelli S., Rota R., Massimi L., Di Rocco C., O'Connell M.A., Gallo A. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J. Biol. Chem. 2008, 283:7251-7260.
24. Maas S., Patt S., Schrey M., Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14687-14692.
25. Ye Z.C., Rothstein J.D., Sontheimer H. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci. 1999, 19:10767-10777.
26. de Groot J.F., Liu T.J., Fuller G., Yung W.K. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Res. 2005, 65:1934-1940.